The term mucosal Schwann cell hamartoma (MSCH) was first proposed by Gibson and Hornick in 2009  to describe a group of neuronal polyps purely composed of S-100–positive Schwann cells, in an attempt to distinguish from true “neuromas” and “neurofibromas.” To our knowledge, only 10 cases have been reported in the literature since it was first described (Table 1). MSCH is currently thought to have no association with any inherited disorder. Herein, we describe a case of MSCH and discuss the morphologic and immunohistochemical features with a differential diagnosis in the gastrointestinal (GI) tract.
A 2-mm-sized rectal polyp was found in a follow-up colonoscopy of a 49-year-old male who has no significant family history of other neuronal lesions or inherited syndromes but had a tubular adenoma resected 2 years prior (Fig. 1A). On microscopic examination, the rectal polyp showed a poorly circumscribed proliferation of spindle cells in the lamina propria, separating the crypt architecture (Fig. 1B). The cells were uniformly elongated, with tapered nuclei and abundant eosinophilic cytoplasm with indistinct cell borders. Nuclear atypia, pleomorphism, or mitosis was not observed (Fig. 1C). On immunohistochemical staining, the cells displayed a strong and diffuse positivity for S-100 in both the nucleus and cytoplasm (Ventana, Roche, Tucson, AZ, USA) (Fig. 1D). In comparison, the cells did not have immunoreactivity for c-Kit, CD34, glial fibrillary acidic protein, epithelial membrane antigen (EMA), smooth muscle actin, or neurofilament protein (NFP). Because the spindle cells did not form a discrete mass but rather an interspersed proliferation between normal structures, the lesion was diagnosed as MSCH.
A diagnosis of MSCH should be made after exclusion of other lesions that resemble spindle cell proliferation and other neuronal tumors. Gastrointestinal stromal tumors, which are the most common spindle cell tumor in the GI tract, can be easily excluded by the characteristic immunoreactivity of c-Kit.
Colorectal neurofibromas are another important differential diagnosis of MSCH because they are also composed of Schwann cells, fibroblasts, perineural cells, and NFP-positive axons and usually form a vague tumor without discrete demarcation. However, they are often associated with neurofibromatosis type 1 (NF1), which is usually accompanied by multiple cutaneous neurofibromas. Colorectal lesion as a primary clinical presentation without skin manifestation is also exceedingly rare .
Mucosal neuromas appear as an ill-defined mass and are composed of hyperplastic nerve fibers arranged in an irregularly ramifying manner . In contrast to our case, mucosal neuromas have perineurial capsules, which are often EMA-positive. They are almost always multiple and a part of the multiple endocrine neoplasia syndrome type IIb (MEN2B), of which the most important component is a medullary thyroid carcinoma.
GI ganglioneuromas are most common in colorectal neuronal lesions and reveal hypercellular stroma composed of mainly S-100–positive Schwann cells. They differ from MSCH in that they are mixed with variable numbers of neuron-specific enolase–positive ganglion cells [1,2]. Solitary polypoid ganglioneuromas are not associated with systemic manifestations ; however, ganglioneuromatous polyposis and diffuse ganglioneuromatosis are associated with Cowden syndrome, Juvenile polyposis syndrome, MEN2B (particularly with diffuse ganglioneuromatosis), and NF1 .
GI schwannomas are composed of bland spindle cells arranged in vague fascicles. Unlike their counterparts from the central nervous system and peripheral soft tissue, the nuclear palisading, so-called Verocay bodies, are absent, which can be similar to MSCH. However, they have characteristic peripheral lymphoid cuffs and form more demarcated tumors than do MSCH [4,5].
Mucosal perineuromas are usually solitary lesions and are characterized by a whorled growth pattern of bland spindle cells that expand the lamina propria , which are morphologically very similar to MSCH. Unlike MSCH, they have colonic epithelium with serrated architecture and express perineural markers such as EMA, whereas they are negative for S-100 protein .
Finally, inflammatory fibroid polyps (Vanek’s tumor) can be confused with MSCH. They are composed of stellate or spindle-shaped, bland stromal cells that are arranged in an onion skin-like pattern around blood vessels and mucosal glands . They have inflammatory infiltrates dominated by eosinophils, which are not observed in MSCH. Additionally, they are not immunoreactive for S-100 and are extremely rare in the colon.
MSCH is a rare benign lesion, and cases with clinical features are summarized in Table 1. Cases are primarily detected as small polyps that range from 1 to 8 mm (mean, 5 mm) and are predominantly located in the rectosigmoid colon. Patients are typically asymptomatic, and none of the patient cases were associated with an inherited syndrome. The clinical features of this case are similar to those summarized in Table 1.
In summary, MSCH is a rare lesion that can be found incidentally during routine colonoscopy. Although there is currently no indication that MSCH is related to inherited syndromes or malignancies, it is important for pathologists to include it in the differential diagnosis of S-100–positive spindle cell proliferative lesions for accurate diagnosis and to prevent aggressive or unnecessary treatments.
Conflicts of Interest
No potential conflict of interest relevant to this article was reported.
1. Gibson JA, Hornick JL. Mucosal Schwann cell “hamartoma”: clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas. Am J Surg Pathol. 2009; 33:781–7.
2. Klair JS, Girotra M, Agarwal A, Aduli F. Mucosal Schwann cell hamartoma: just benign or more? Int J Colorectal Dis. 2014; 29:1597–8.
3. Bae MN, Lee JE, Bae SM, et al. Mucosal Schwann-cell hamartoma diagnosed by using an endoscopic snare polypectomy. Ann Coloproctol. 2013; 29:130–4.
4. Neis B, Hart P, Chandran V, Kane S. Mucosal schwann cell hamartoma of the colon in a patient with ulcerative colitis. Gastroenterol Hepatol (N Y). 2013; 9:183–5.
5. Rocco EG, Iannuzzi F, Dell’Era A, et al. Schwann cell hamartoma: case report. BMC Gastroenterol. 2011; 11:68.
6. Pasquini P, Baiocchini A, Falasca L, et al. Mucosal Schwann cell “Hamartoma”: a new entity? World J Gastroenterol. 2009; 15:2287–9.
7. Sagami S, Fukumoto A, Amano M, et al. A case of mucosal Schwann cell hamartoma. Nihon Shokakibyo Gakkai Zasshi. 2012; 109:1776–83.
8. Ferro de Beça F, Lopes J, Maçoas F, Carneiro F, Lopes JM. Tactoid body features in a Schwann cell hamartoma of colonic mucosa. Int J Surg Pathol. 2014; 22:438–41.
9. Kanar O, Nakshabendi R, Berry AC. Colonic mucosal Schwann cell hamartoma on incidental screening colonoscopy. J Gastrointestin Liver Dis. 2015; 24:411.